Current evaluations for scientists create perverse incentives. To avoid this issue, I propose an N-best policy: Hiring and promotion committees should solicit a few research products as the primary locus of evaluation. This policy aligns evaluation with the goal of selecting scientists who produce high-quality work. Read Full Article (External Site) Dr. David LowemannDr. David […]

At present, with the development of an aging society and an increase in the number of elderly people, in order to ensure the ability and enthusiasm of the elderly to live independently, it is necessary to ensure that they can understand the world in a normal way. More and more elderly people have cognitive impairment, […]

Alzheimer’s disease (AD) is a complex, multi-factorial disease affecting various brain systems. This complexity implies that successful therapies must be directed against several core neuropathological targets rather than single ones. The scientific community has made great efforts to identify the right AD targets beside the historic amyloid-β (Aβ). Neuroinflammation is re-emerging as determinant in the […]